The accelerator will provide economic and intellectual capital to further a discovery’s potential for commercialization
Welcome to the sixth installment of Benchside Dispatch, a series of interviews with top researchers in the field of dermatology intended to highlight important advances in the care of medical skin disorders.
Posted in: Interviews, Latest News
Related: Benchside Dispatches, Pemphigus Vulgaris
Welcome to the fifth installment of Benchside Dispatches. In this installment, Angela Christiano, PhD, discusses epider molysis bullosa (EB). Dr. Christiano is the Richard and Mildred Rhodebeck Professor of Dermatology and Professor of Genetics & Development and Director, Basic Science Research Group of Dermatology at Columbia University College of Physicians & Surgeons.
Posted in: Interviews, Latest News
Related: Epidermolysis bullosa
In this installment, Steven Q. Wang, MD, discusses photoprotection. Dr. Wang is a board certified dermatologist and Director of Dermatologic Surgery and Dermatology at the Memorial Sloan-Kettering Cancer Center in Basking Ridge, New Jersey.
Posted in: Interviews, Latest News
Related: Benchside Dispatches
Since the 1950s, the number of new drugs approved by the Food and Drug Administration per $1 billion invested in research and development has fallen 80-fold (Scannell et al., 2012).
Posted in: Articles, Latest News
Related: JID
Posted in: Interviews, Latest News
Related: Benchside Dispatches, Psoriasis
Mar 12, 2018
Innovative Technologies Signal Bright Future for the Field of Dermatology
Jan 18, 2017
Benchside Dispatches: An interview with Masayuki Amagai, MD, PhD
Advancing Innovation in Dermatology Inc. is a nonprofit, tax-exempt charitable organization under Section 501(c)(3) of the Internal Revenue Code. | Donations are tax-deductible as allowed by law.
© 2018 Advancing Innovation in Dermatology Inc.. All Rights Reserved. | Web Design & Development time4design - Bucks County Web Design.